AMCP encourages schools and colleges of pharmacy to ensure the provision of a balanced, general education, including information regarding emerging technologies and health care systems, to graduate educated and competent health care professionals.
Provider Status
| Collaborative Drug Therapy Management Policy 9903 11/01/1999 Introduced 03/01/2004 Reapproved 12/01/2008 Reapproved 06/01/2011 Revised 10/01/2012 Reapproved 10/18/2021 Revised | AMCP supports the concept of collaborative drug therapy management (CDTM) a formal partnership between a pharmacist and a prescriber that allows the pharmacist to manage a patient’s drug therapy. CDTM, also referred to as collaborative practice, allows pharmacists to use their unique skills and abilities to complement other types of care provided by collaborating professionals to optimize patient outcomes. When pharmacists practice under CDTM agreements, health care services and outcomes are optimized when compared with settings where pharmacists were not involved. (See AMCP Managed Care Pharmacy Practice Positions -Collaborative Drug Therapy Management). |
Disease Management 11/01/1999 Introduced | AMCP supports disease management as the concept of reducing health care costs, closing gaps in care, and improving quality of life for individuals with chronic conditions by preventing or minimizing the effects of the disease through integrated medical and pharmacy management. Disease management programs are designed to improve health outcomes and reduce associated costs from avoidable complications and medication adverse events by identifying and treating chronic conditions more quickly and effectively, and improving appropriate medication use and adherence, thus slowing the progression of those diseases. AMCP recognizes that, as a trained medication management specialist, the pharmacist has clinical expertise and a leadership role to play in the collaborative development, implementation and improvement of disease management programs. (See AMCP Concepts in Managed Care Pharmacy – Disease Management) |
Evidence-based Clinical Practice Guidelines
| AMCP advocates direct involvement of pharmacists in the development, evaluation, and implementation of evidence-based clinical practice guidelines that focus on an interdisciplinary team approach to patient care. |
| Health Care Team Approach to Optimal Therapeutic Outcomes Policy 0014 02/01/2000 Introduced 02/01/2005 Reapproved 02/01/2010 Reapproved 04/07/2015 Revised | AMCP believes that achieving optimal therapeutic outcomes for each patient is a shared responsibility of the health care team. AMCP further supports the active role of the pharmacist in the development, implementation and monitoring of therapeutic plans, which include provider communication and assisting patients to become informed decision makers to improve adherence with their prescribed therapeutic plan. |
| Pharmacy CPT Codes Policy 0022 02/01/2000 Introduced 02/01/2005 Reapproved 11/01/2009 Reapproved 02/01/2014 Reapproved 04/29/2020 Revised | AMCP supports the use and expansion of pharmacy-specific codes listed in the American Medical Association's Physicians' Current Procedural Terminology (CPT) coding structure to assist pharmacists in documenting professional services as health care providers. |
Pharmacy Benefits for the Uninsured/Underinsured
| AMCP supports the equitable access to medications and the development of integrated systems that optimize public and private programs such as 340B, Patient Assistance Programs (PAP) and charitable medication distributors to ensure access to enhanced pharmacy services and pharmaceutical products for all patients, regardless of insurance coverage or income. In addition, AMCP encourages innovations that provide affordable medication access such as comparing a PBM's network price, access to discounted drug retailers and point of care eligibility for PAP. |
Transitions of Care
Policy 2002
11/17/2020 Introduced | Transition of care is the movement of patients from one health care practitioner or setting to another as their condition and care needs change. It occurs 1) within settings, such as primary care and specialty care in the context of care in the community, 2) between settings, such as someone who moves from the hospital to the rehabilitation facility, and it occurs 3) based on health status, such as moving from curative to palliative care. AMCP supports the role of pharmacists in ensuring the continuity of a patient’s medication therapy regimen when moving among these diverse health care settings. Pharmacists analyze and communicate information about the safety, effectiveness and outcomes of drug therapy to other health care providers to ensure appropriate continuity of drug therapy. Additionally, pharmacists serve the needs of patients and caregivers by providing consultation that helps them understand their medication, the dosing and possible side effects while encouraging adherence as the patient moves from one setting to another. |
Related
From the AMCP Policy Digest, AMCP's policies regarding research.
From the AMCP Policy Digest, AMCP's policies regarding formulary management.
Featured News & Resources
See Full CalendarUpcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
